StepStone »

Eikon Therapeutics shares owned by StepStone

Quarter-by-quarter ownership of Eikon Therapeutics shares owned by StepStone from 13F filings

Historical chart of StepStone investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by StepStone consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by StepStone

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 395k 10.58

More positions owned by StepStone

Karman Hldgs Common Stock (KRMN)
Stubhub Hldgs Cl A (STUB)
Xanadu Quantum Technolo Sub Vtg B (XNDU)
Onkure Therapeutics Com Cl A (OKUR)
Uipath Cl A (PATH)
Kodiak Ai (KDK)
Entrada Therapeutics (TRDA)
Navan Cl A (NAVN)
Phathom Pharmaceuticals (PHAT)
Eikon Therapeutics
Draftkings Com Cl A (DKNG)
Chime Finl Com Shs Cl A (CHYM)
Mongodb Cl A (MDB)
Grove Collaborative Hold Com Cl A (GROV)
Tenaya Therapeutics (TNYA)

View all positions for StepStone

Top funds holding Eikon Therapeutics

BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors
General Catalyst Group Management

View all funds holding Eikon Therapeutics